MiMedx Group, Inc. (MDXG)
NASDAQ·Healthcare·Biotechnology
$3.40
+1.65%
Mkt Cap $509.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $106.78M | $118.09M | +10.60% | $0.09 | $0.14 | +55.56% | — | — |
| Q4 2025 Oct 29, 2025 | $106.93M | $113.72M | +6.35% | $0.07 | $0.15 | +114.29% | — | — |
| Q3 2025 Jul 30, 2025 | $93.32M | $98.61M | +5.66% | $0.06 | $0.10 | +66.67% | — | — |
| Q2 2025 Apr 30, 2025 | $86.32M | $88.20M | +2.18% | $0.06 | $0.06 | +0.00% | — | — |
| Q1 2025 Feb 26, 2025 | $89.42M | $92.91M | +3.90% | $0.07 | $0.07 | +0.00% | — | — |
| Q4 2024 Oct 30, 2024 | $89.42M | $84.06M | -6.00% | $0.04 | $0.05 | +13.64% | — | — |
| Q3 2024 Jul 31, 2024 | $88.92M | $87.21M | -1.93% | $0.08 | $0.08 | +0.00% | — | — |
| Q2 2024 Apr 30, 2024 | $79.36M | $84.71M | +6.74% | $0.05 | $0.07 | +40.00% | — | — |
| Q1 2024 Feb 28, 2024 | $85.05M | $86.83M | +2.10% | $0.08 | $0.04 | -50.00% | — | — |
| Q4 2023 Oct 30, 2023 | $85.05M | $81.71M | -3.92% | $0.05 | $0.06 | +20.00% | — | — |
| Q3 2023 Aug 1, 2023 | $74.83M | $81.26M | +8.59% | $0.01 | $0.01 | +100.00% | — | — |
| Q2 2023 May 2, 2023 | $64.15M | $71.68M | +11.73% | -$0.09 | -$0.06 | +33.33% | — | — |
| Q2 2023 May 1, 2023 | — | $74.38M | — | — | -$0.00 | — | — | — |
| Q4 2022 Nov 2, 2022 | $66.73M | $67.69M | +1.44% | -$0.09 | -$0.09 | +0.00% | — | — |
| Q3 2022 Aug 2, 2022 | $65.07M | $66.88M | +2.79% | -$0.06 | -$0.11 | -83.33% | — | — |
| Q2 2022 May 3, 2022 | $54.10M | $58.89M | +8.86% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q1 2022 Feb 28, 2022 | $63.69M | $67.41M | +5.84% | $0.00 | $0.01 | +129.89% | — | — |
| Q4 2021 Nov 2, 2021 | $60.26M | $63.07M | +4.67% | -$0.08 | -$0.04 | +50.00% | — | — |
| Q3 2021 Aug 3, 2021 | $58.77M | $68.17M | +15.99% | -$0.07 | -$0.03 | +57.14% | — | — |
| Q2 2021 Apr 28, 2021 | $82.38M | $59.97M | -27.20% | -$0.19 | -$0.09 | +52.63% | — | — |